Skip to content

Effect of dexmedetomidine on median effective dose of nalbuphine analgesia in elderly patients after laparoscopic colorectal surgery

Effect of dexmedetomidine on median effective dose of nalbuphine analgesia in elderly patients after laparoscopic colorectal surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060702
Enrollment
Unknown
Registered
2022-06-08
Start date
2022-09-10
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic colorectal surgery

Interventions

Group A:no dexmedetomidine
Group B:dexmedetomidine 1.0 µg/kg
Group C:dexmedetomidine 2.0 µg/kg

Sponsors

ShengJing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Aged 65–85 years; 2.American society of anesthesiologists(ASA) grade I–III; 3.Body mass index (BMI) <=30 kg/m2; 4.Cardiac function grade I–III; 5.Provision of written informed consent by the patient and family members.

Exclusion criteria

Exclusion criteria: 1.Serious heart or respiratory disease; 2.Serious arrhythmia; 3.Liver and kidney function impairment; 4.Known allergy or hypersensitivity to any of the medications used in the study; 5.History of chronic pain; 6.Coagulation disorder; 7.Mental illness or a history of dependence on sedative drugs; 8.Lack of ability to understand the visual analogue scale (VAS) system.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
Bruggman comfort scale;mean arterial pressure;heart rate;operation time;anesthesia time;

Countries

China

Contacts

Public ContactJingjing Jiang

Shengjing Hospital of China Medical University

jjj_sj@163.com+86 24 96615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026